Key result
Patients undergoing total hip replacement in high-transfusion hospitals had higher odds of receiving RBC transfusions compared to average-transfusion hospitals.
Why the study?
Does the hospital of treatment affect the likelihood of receiving blood transfusions in patients undergoing major noncardiac surgery?
Observational
Yes
Does the hospital of treatment affect the likelihood of receiving blood transfusions in patients undergoing major noncardiac surgery?
Answers are grounded in this paper and cite their sources.
There is dramatic hospital-level variability in perioperative blood transfusion rates for major noncardiac surgery at US academic medical centers, independent of patient risk factors.
In Brief Objective: To examine the hospital variability in use of red blood cells (RBCs), fresh-frozen plasma (FFP), and platelet transfusions in patients undergoing major noncardiac surgery. Background: Blood transfusion is commonly used in surgical procedures in the United States. Little is known about the hospital variability in perioperative transfusion rates for noncardiac surgery. Methods: We used the University HealthSystem Consortium database (2006–2010) to examine hospital variability in use of allogeneic RBC, FFP, and platelet transfusions in patients undergoing major noncardiac surgery. We used regression-based techniques to quantify the variability in hospital transfusion practices and to study the association between hospital characteristics and the likelihood of transfusion. Results: After adjusting for patient risk factors, hospital transfusion rates varied widely for patients undergoing total hip replacement (THR), colectomy, and pancreaticoduodenectomy. Compared with patients undergoing THR in average-transfusion hospitals, patients treated in high-transfusion hospitals have a greater than twofold higher odds of being transfused with RBCs [adjusted odds ratio (AOR) = 2.41; 95% confidence interval (CI), 1.89–3.09], FFP (AOR = 2.81; 95% CI, 2.02–3.91), and platelets (AOR = 2.52; 95% CI, 1.95–3.25), whereas patients in low-transfusion hospitals have an approximately 50% lower odds of receiving RBCs (AOR = 0.45; 95% CI, 0.35–0.57), FFP (AOR = 0.37; 95% CI, 0.27–0.51), and platelets (AOR = 0.42; 95% CI, 0.29–0.62). Similar results were obtained for colectomy and pancreaticoduodenectomy. Conclusions: There was dramatic hospital variability in perioperative transfusion rates among patients undergoing major noncardiac surgery at academic medical centers. In light of the potential complications of transfusion therapy, reducing this variability in hospital transfusion practices may result in improved surgical outcomes. Little is known about the hospital variability in perioperative transfusion rates for noncardiac surgery. We examined the hospital variability in use of red blood cells, fresh-frozen plasma, and platelet transfusions in patients undergoing major noncardiac surgery. We found that there was dramatic hospital variability in perioperative transfusion rates at academic medical centers.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2012) conducted an observational in Major noncardiac surgery. Treatment in high-transfusion hospitals vs. Treatment in average-transfusion hospitals was evaluated on Use of allogeneic RBC, FFP, and platelet transfusions (AOR 2.41, 95% CI 1.89-3.09). Patients undergoing total hip replacement in high-transfusion hospitals had higher odds of receiving RBC transfusions compared to average-transfusion hospitals.
Synapse has enriched 10 related papers. Consider them for comparative context: